Vilazodone is acclimated to
amusement depression. Vilazodone is in a chic of medications alleged careful
serotonin reuptake inhibitors (SSRIs) and is aswell a 5HT1A receptor fractional
agonist. It works by accretion the bulk of serotonin, a accustomed actuality in
the academician that helps advance brainy balance.
According to two eight-week,
randomized, double-blind, placebo-controlled trials in adults, vilazodone
elicits an antidepressant acknowledgment afterwards one anniversary of
treatment. Afterwards eight weeks, capacity assigned to vilazodone 40 mg
circadian dosage (titrated over 2 weeks) accomplished a decidedly college
acknowledgment amount than the accumulation accustomed placebo (44% vs 30%, P =
.002). Remission ante for vilazodone were not decidedly altered against placebo.
According to an commodity on
the United States approval of vilazodone accounting by FDA staff, "it is
alien whether [vilazodone] has any advantages compared to added drugs in the
antidepressant class."
